Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
Status:
Terminated
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended
curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol
injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation
therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).